首页> 外国专利> New 2,3,4,6-tetra-substituted pyridines, useful as pharmaceuticals and plant-protection agents, prepared using an alkoxyallene as three-carbon synthon

New 2,3,4,6-tetra-substituted pyridines, useful as pharmaceuticals and plant-protection agents, prepared using an alkoxyallene as three-carbon synthon

机译:新的2,3,4,6-四取代吡啶,用作药物和植物保护剂,使用烷氧基丙二烯作为三碳合成子制备

摘要

2,3,4,6-tetra-substituted pyridines and their tautomeric pyridones are new. 2,3,4,6-tetra-substituted pyridines of formula (I), and their tautomeric pyridones when R3 = hydroxy, are new. [Image] R1alkyl, aryl or alkenyl, all optionally substituted; R2alkoxy or cycloalkoxy, preferably unsubstituted 1-12C alkoxy and especially methoxy, ethoxy, 1- or 2-propoxy, 1- or tert-butoxy; R3hydroxy, halo, trifluoromethanesulfonate, nonabromobutanesulfonate, p-toluenesulfonate, p-(bromo or nitro)benzenesulfonate, methanesulfonate, 2,2,2-trifluoroethanesulfonate, or, all optionally substituted, alkyl, alkenyl, ethynyl (substituted by R5), aryl, alkoxy, cycloalkoxy (especially optionally substituted 1-12C alkoxy), N-nucleophiles (especially ammonia, primary or secondary amines, azides) or sulfur-nucleophiles (especially thiols); R5hydrogen, aryl, alkyl, alkenyl, all optionally substituted; R4fluorinated alkyl, especially of formula -[(CFlHm)t-(CFnHo)u-(CFpHq)v]w-(CFrHs); each of l, n, p, m, o and q : 0-2, provided l+m, n+o and p+q = 2; each of r and s : 0-3, but must total 3, and l+n+p+r = at least 1; each t, u and v : 0-3; w : 0-10. Independent claims are also included for the following: (1) method for preparing (I) by sequential reaction of an alkoxyallene (II) with R1CN and R4COOH; and (2) use of (II) as 3-carbon building block in synthesis of pyridines, particularly (I).
机译:2,3,4,6-四取代的吡啶及其互变异构吡啶酮是新的。当R 3> =羟基时,式(I)的2,3,4,6-四取代的吡啶和它们的互变异构吡啶酮是新的。 [图像] R1>烷基,芳基或烯基,全部任选地被取代; R2>烷氧基或环烷氧基,优选未取代的1-12C烷氧基,尤其是甲氧基,乙氧基,1-或2-丙氧基,1-或叔丁氧基; R 3>羟基,卤素,三氟甲磺酸盐,九溴丁烷磺酸盐,对甲苯磺酸盐,对-(溴或硝基)苯磺酸盐,甲磺酸盐,2,2,2-三氟乙磺酸盐或所有任选取代的烷基,烯基,乙炔基(被R5>取代) ,芳基,烷氧基,环烷氧基(特别是任选取代的1-12C烷氧基),N-亲核试剂(特别是氨,伯或仲胺,叠氮化物)或硫亲核试剂(特别是硫醇); R5>氢,芳基,烷基,烯基,所有任选取代的; R4>氟化的烷基,特别是式-[((CFlHm)t-(CFnHo)u-(CFpHq)v] w-(CFrHs); l,n,p,m,o和q分别为0-2,前提是l + m,n + o和p + q = 2; r和s各自为0-3,但必须总计为3,并且l + n + p + r =至少为1; t,u和v分别为0-3; w:0-10。还包括以下方面的独立权利要求:(1)通过使烷氧基丙二烯(II)与R 1> CN和R 4> COOH顺序反应来制备(I)的方法; (2)在合成吡啶,特别是(I)中使用(II)作为3-碳结构单元。

著录项

  • 公开/公告号DE10336497A1

    专利类型

  • 公开/公告日2005-03-03

    原文格式PDF

  • 申请/专利权人 FREIE UNIVERSITAET BERLIN;

    申请/专利号DE2003136497

  • 发明设计人 FLOEGEL OLIVER;REISIG HANS-ULRICH;

    申请日2003-08-08

  • 分类号C07D213/69;C07D213/26;

  • 国家 DE

  • 入库时间 2022-08-21 22:01:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号